DESIGN OVERVIEW
- Epoxy finish floors in core area, all floor edges are coved & polished to minimize dust and dirt adherences.
- All the electrical and utility lines are either taken outside or concealed with in the walls or false sealing.
- All the luminaries are flushed with the ceiling and electrical control panels and the switches are flushed with the walls
- The corridors & windows are designed to enhance the viewing of the manufacturing operations without physically entering the processing areas.
- Materials are stored as per there storage conditions.
- Illumination of all the manufacturing areas has designed to meet standard, taking care of lumens.
- There is pest and rodent control program for the facility and all entry points to the plant are provided with the insectocutor and air curtains.
- Fire extinguisher is located throughout the facility.
- There are emergency exits at suitable places.
- Packing areas construction and finishing of the primary packaging areas is similar to process areas.
- Secondary packaging areas have plastered bricks walls with smooth paint finish.
- The roof is RCC; floor is of granite polished stone.
Approved
Under Approval
Namibia
Tanzania
| LIQUID | 2 MILLION BOTTLES PER MONTH |
| SACHET | 2 MILLION SACHET PER MONTH |
| CAPSULES | 10 MILLION PER MONTH |
| TABLETS | 60 MILLION PER MONTH |
Tablets (General Category)
- Immediate Release
- Sustained Release
- Extended Release
- Delayed Release
- Enteric Coated
- Oral Dispersible Tablet (ODT)
- Mouth Dissolving tablet (MD)
- Modified release
Capsules
- Delayed Release
- Sustained Release
- Enteric Release
- Tablet in capsule
- Tablet and Granules in Capsule
- Immediate Release
Sachets
- ODT Sachet
- Mouth Dissolving Sachet
- Micro Pellets (where use of active is less than 1 gm per dose) – Montelukast Sachet, Esomeprazole Sachet.
